Search results for "PERT"

showing 10 items of 7689 documents

Causality-based diagnosis of histamine-related cardiorespiratory disturbances in surgical patients

1998

medicine.medical_specialtyNeurologyImmunologyPharmacology toxicologyHistamine ReleaseSkin Diseaseschemistry.chemical_compoundDouble-Blind MethodTachycardiaInternal medicineBradycardiamedicineHumansIntensive care medicineAnaphylaxisPharmacologybusiness.industryCardiorespiratory fitnessCausalityRheumatologyHistamine H2 AntagonistschemistryHypertensionHistamine H1 AntagonistsHypotensionbusinessHistamineHistamineSurgical patientsInflammation Research
researchProduct

Efficacy, tolerability and influence on "quality of life" of nifedipine GITS versus amlodipine in elderly patients with mild-moderate hypertension.

2001

The main purpose of this study was to compare efficacy, tolerability and influence on quality of life (QOL) of nifedipine gastrointestinal therapeutic system (NI) 30-60 mg once a day vs amlodipine (AM) 5-10 mg once a day in elderly patients with mild-moderate hypertension.This was a randomized, double-blind, parallel-group, multicenter study. After a 2-week single-blind placebo run-in, patients were randomized to either NI 30 mg or AM 5 mg. Responders continued on the same dosage for 16 additional weeks, while non-responders were titrated to 60 mg NI or 10 mg AM.Blood pressure was measured by mercury sphygmomanometer and efficacy equivalence of NI and AM tested by covariance analysis. Diast…

medicine.medical_specialtyNifedipinemedicine.medical_treatmentBlood PressurePlaceboNifedipineQuality of lifeDouble-Blind MethodInternal MedicinemedicineHumansAmlodipineAgedAged 80 and overChemotherapybusiness.industryGeneral MedicineMiddle AgedCalcium Channel BlockersSurgeryNifedipine gitsBlood pressureTolerabilityTherapeutic EquivalencyAnesthesiaHypertensionQuality of LifeAmlodipineCardiology and Cardiovascular Medicinebusinessmedicine.drugBlood pressure
researchProduct

Nitric oxide in the pathogenesis of vascular disease

2000

Nitric oxide (NO) is synthesized by at least three distinct isoforms of NO synthase (NOS). Their substrate and cofactor requirements are very similar. All three isoforms have some implications, physiological or pathophysiological, in the cardiovascular system. The endothelial NOS III is physiologically important for vascular homeostasis, keeping the vasculature dilated, protecting the intima from platelet aggregates and leukocyte adhesion, and preventing smooth muscle proliferation. Central and peripheral neuronal NOS I may also contribute to blood pressure regulation. Vascular disease associated with hypercholesterolaemia, diabetes, and hypertension is characterized by endothelial dysfunct…

medicine.medical_specialtyNitric Oxide Synthase Type IIIHypercholesterolemiaNitric Oxide Synthase Type IIVasodilationNitric OxideEndothelial NOSPathology and Forensic MedicineNitric oxidePathogenesischemistry.chemical_compoundInternal medicineHumansMedicineEndothelial dysfunctionbiologybusiness.industryVascular diseasemedicine.diseaseNitric oxide synthaseEndothelial stem cellOxidative StressEndocrinologychemistryCardiovascular DiseasesHypertensionbiology.proteinEndothelium VascularNitric Oxide SynthasebusinessDiabetic AngiopathiesThe Journal of Pathology
researchProduct

Non-pharmacological treatment of hypertension in primary health care: A comparative clinical trial of two education strategies in health and nutrition

2011

Abstract Background Poor adherence to non-pharmacological treatment of hypertension represents a serious challenge for public health policies in several countries. This study was conducted to compare two intervention strategies regarding the adherence of adult women to dietary changes recommended for the treatment of hypertension in a community covered by Primary Health Care Unit. Methods This study is a randomized controlled trial of a sample composed of 28 women with hypertension enrolled in the Primary Health Care Unit located in the urban area of southeastern Brazil. The participants were already undergoing treatment for hypertension but devoid of nutritional care; and were divided into…

medicine.medical_specialtyNon-pharmacologicalEducationlaw.inventionPatient Education as TopicRandomized controlled trialHealth and nutritionlawEnvironmental healthInternal medicineEpidemiologyHealth careHumansMedicineNutritional Physiological PhenomenaPrimary Health Carebusiness.industrylcsh:Public aspects of medicinePublic healthPublic Health Environmental and Occupational HealthHealth services researchlcsh:RA1-1270Middle AgedHouse CallsClinical trialBlood pressureHypertensionPatient ComplianceWomen's HealthFemaleHealth educationGuideline AdherenceHealth Services ResearchbusinessResearch Article
researchProduct

Panel performance and memory in visually impaired versus sighted panels

2020

International audience; No abstract

medicine.medical_specialtyNutrition and Dieteticssemantic memoryVisually impaired05 social sciences[SDV.NEU.SC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive SciencesAudiology050105 experimental psychology03 medical and health sciences0302 clinical medicinesmellmedicineexpertise0501 psychology and cognitive sciencesassessorsPsychology[SDV.AEN]Life Sciences [q-bio]/Food and NutritionComputingMilieux_MISCELLANEOUS030217 neurology & neurosurgeryblindnessFood ScienceFood Quality and Preference
researchProduct

Changes in ocular signs and symptoms when switching from preserved latanoprost 0.005% to preservative-free tafluprost 0.0015%: phase IIIb study in pa…

2008

Purpose This open-label, multinational, phase IIIb study investigated the changes in ocular signs and symptoms when patients were switched from preserved latanoprost 0.005% to preservative-free tafluprost 0.0015% (q.d. at 20:00) for 12 weeks. Methods Patients with open-angle glaucoma or ocular hypertension who had received latanoprost for at least 6 months and had at least 2 ocular symptoms or one symptom and one sign were enrolled (n=158). Change from screening in ocular symptoms and signs were the main endpoints. Data from the 6-week analysis are reported here. Results After switching to preservative-free tafluprost, the proportion of patients with at least mild symptoms decreased: irrita…

medicine.medical_specialtyOpen angle glaucomabusiness.industryTafluprostOcular hypertensionGlaucomaGeneral Medicinemedicine.diseasemedicine.disease_causeeye diseasesOphthalmologychemistry.chemical_compoundchemistryOphthalmologyMedicineItchingsense organsmedicine.symptomIrritationLatanoprostbusinessBlepharitismedicine.drugActa Ophthalmologica
researchProduct

Executive summary of the joint position paper on renal denervation of the Cardiovascular and Interventional Radiological Society of Europe and the Eu…

2016

Renal denervation (RDN) was reported as a novel exciting treatment for resistant hypertension in 2009. An initial randomized trial supported its efficacy and the technique gained rapid acceptance across the globe. However, a subsequent large blinded, sham arm randomized trial conducted in the USA (to gain Food and Drug Administration approval) failed to achieve its primary efficacy end point in reducing office blood pressure at 6 months. Published in 2014 this trial received both widespread praise and criticism. RDN has effectively stopped out with clinical trials pending further evidence. This joint consensus document representing the European Society of Hypertension and the Cardiovascular…

medicine.medical_specialtyPathologyConsensusPhysiologyCoronary VasospasmBlood PressureConsensu030204 cardiovascular system & hematologyKidneylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawmedicineInternal MedicineHumans030212 general & internal medicineConsensus documentDenervationExecutive summarymedicine.diagnostic_testbusiness.industryInterventional radiologymedicine.diseaseDenervationResistant hypertensionBlood pressureRadiological weaponCoronary vasospasmHypertensionPractice Guidelines as TopicPhysical therapyPosition paperRenal denervationbusinessCardiology and Cardiovascular MedicineHumanJournal of hypertension
researchProduct

Syndrome of autosomal recessive polycystic kidneys with skeletal and facial anomalies is not linked to the ARPKD gene locus on chromosome 6p

2000

We report on two sibs, both males, one born at 37 the other at 24 weeks of gestation, both with a syndrome similar to that seen in three sets of sibs by Gillessen-Kaesbach et al. [1993: Am J Med Genet 45:511–518]. Both propositi had polycystic kidneys and hepatic fibrosis indistinguishable from that seen in autosomal recessive polycystic kidney disease (ARPKD), and skeletal and facial anomalies. Skeletal abnormalities included “butterfly” vertebrae, square shape of pelvis, and brachymelia. The facial anomalies included hypertelorism, epicanthic folds, and anteverted nares. Additional external findings were apparently low-set ears and a short neck. Histopathological examination of the kidney…

medicine.medical_specialtyPathologyGenetic heterogeneityBiologyCystic Changemedicine.diseaseAutosomal Recessive Polycystic Kidney DiseaseEndocrinologyGenetic linkageInternal medicinemedicineCystHypertelorismmedicine.symptomGenetics (clinical)Potter SyndromeKidney diseaseAmerican Journal of Medical Genetics
researchProduct

Distribution of type I and type II collagen gene expression during the development of human long bones

1990

The temporal and spatial gene expression of collagen type I and type II during the development of the human long bones was studied by the technique of in situ hybridization covering the period from the cartilagenous bone anlage to the formation of a regular growth plate in the newborn. Analysis of the early stages around the seventh week of gestation revealed for type II collagen a strong hybridization signal limited to the chondrogenic tissue. The surrounding connective tissue and the perichondrium showed weak type I collagen expression, while the zones of desmal ossification like the clavicle gave a strong signal. Beginning with the eighth week of gestation, type I collagen mRNA was detec…

medicine.medical_specialtyPathologyHistologyPhysiologyEndocrinology Diabetes and MetabolismType II collagenGene ExpressionConnective tissueBiologyBone and BonesInternal medicinemedicineHumansPerichondriumBone DevelopmentOssificationCartilageNucleic Acid HybridizationDNAHypertrophymedicine.diseaseCollagen type I alpha 1Cartilagemedicine.anatomical_structureEndocrinologyCollagenmedicine.symptomDNA ProbesType I collagenCalcificationBone
researchProduct

The Effects of Renal Denervation on Renal Hemodynamics and Renal Vasculature in a Porcine Model

2015

Rationale Recently, the efficacy of renal denervation (RDN) has been debated. It is discussed whether RDN is able to adequately target the renal nerves. Objective We aimed to investigate how effective RDN was by means of functional hemodynamic measurements and nerve damage on histology. Methods and Results We performed hemodynamic measurements in both renal arteries of healthy pigs using a Doppler flow and pressure wire. Subsequently unilateral denervation was performed, followed by repeated bilateral hemodynamic measurements. Pigs were terminated directly after RDN or were followed for 3 weeks or 3 months after the procedure. After termination, both treated and control arteries were prepar…

medicine.medical_specialtyPathologySympathetic Nervous SystemSwineUrologylcsh:MedicineHemodynamicsKidneyRenal CirculationLesionRenal ArteryAdventitiamedicine.arteryPressuremedicineAnimalsHumansRenal arterylcsh:ScienceDenervationKidneyMultidisciplinaryRenal circulationbusiness.industrylcsh:RHemodynamicsDenervationmedicine.anatomical_structureRenal blood flowHypertensionlcsh:Qmedicine.symptombusinessResearch ArticlePLOS ONE
researchProduct